Researcher interests: Tumor microenvironment and angiogenesis. Tissue response and resistance to anti-angiogenic therapy. Developing nanotechnology-based anti-angiogenic and anti-cancer with reduced tumor resistance and prolonged efficacy and tumor targeting. Anti-metastatic drugs. Ocular drug delivery systems for treating neovascular eye disease.
FACULTY / SCHOOL: School of Medicine - IMRIC

Selected Publications

Adi Lahiani, Ofra Benny, Cezary Marcinkiewicz and Philip Lazarovici, Efrat Noy, Gadi Cohen, Hanoch Senderowitz, Jehoshua Katzehendler, Johannes A. Eble, Tatjana Momic
Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α1β1/α2β1 Integrins with Antiangiogenic Activity (2014)| ASPET| Read more
Akiko Mammoto, and Mark W. Kieran, Arja Kaipainen, Ofra Benny, Bora Inceoglu, Brian T. Kalish, Bruce D. Hammock, Catherine E. Butterfield, Craig R. Lee, Darryl C. Zeldin, Dayna K. Mudge, Diane R. Bielenberg, Donald E. Ingber, Fred B. Lih, Hau D. Le, John R. Falck, Jun Yang, Kenneth B. Tomer, Mark Puder, Mary A. Simpson, Matthew L. Edin, Patricia A. D’Amore, Roger L. Jenkins, Sui Huang, Tadanori Mammoto, tissue regeneration Dipak Panigrahy, Tomoshige Akino, Vijaya L. Manthati
Epoxyeicosanoids promote organ and tissue regeneration (2013)| PNAS| Read more
Alejandro Soto-Gutierrez, Ofra Benny, Carolyn W. Lee-Parsons, Hiroshi Yagi, Hongyun Wang, Jonathan Goldwasser, Maria Shulman, Martin L. Yarmush, Merav Cohen, Yaakov Nahmias
Enhancement of Naringenin Bioavailability by Complexation with Hydroxypropoyl-β-Cyclodextrin (2011)| Plos One| Read more

Contact for more information:

Shani Bullock
VP, Business Development, Healthcare
+972-2-6586608
Contact ME: